Coloplast A/S (CPH:COLO.B)
Denmark · Delayed Price · Currency is DKK 435.90
+11.40 (2.69%)
Oct 9, 2026, 4:59 PM CET
Coloplast Ratios and Metrics
Market cap in millions DKK. Fiscal year is October - September.
Millions DKK. Fiscal year is Oct - Sep.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 98,151 | 122,266 | 196,855 | 167,956 | 164,708 | 214,092 | |
Market Cap Growth | -24.19% | -37.89% | 17.21% | 1.97% | -23.07% | 0.31% |
Enterprise Value | 121,137 | 145,755 | 220,492 | 189,216 | 184,449 | 217,698 |
Last Close Price | 435.90 | 519.71 | 814.78 | 677.77 | 687.34 | 875.14 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
PE Ratio | 35.55 | 33.63 | 38.97 | 35.12 | 35.00 | 44.37 |
Forward PE | 17.54 | 21.87 | 35.61 | 27.34 | 28.98 | 41.10 |
PS Ratio | 3.45 | 4.39 | 7.28 | 6.86 | 7.30 | 11.02 |
PB Ratio | 7.34 | 7.58 | 10.97 | 9.71 | 19.86 | 26.21 |
P/TBV Ratio | - | - | - | - | - | 46.53 |
P/FCF Ratio | 15.65 | 22.90 | 123.04 | 52.39 | 39.48 | 48.98 |
P/OCF Ratio | 12.79 | 18.40 | 71.17 | 39.74 | 32.30 | 40.47 |
PEG Ratio | 2.13 | 2.25 | 3.71 | 2.69 | 2.93 | 4.85 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
EV/Sales Ratio | 4.26 | 5.23 | 8.16 | 7.72 | 8.17 | 11.21 |
EV/EBITDA Ratio | 13.59 | 16.89 | 26.92 | 25.00 | 24.45 | 31.56 |
EV/EBIT Ratio | 15.79 | 18.88 | 30.17 | 27.63 | 26.66 | 34.24 |
EV/FCF Ratio | 19.32 | 27.30 | 137.81 | 59.02 | 44.21 | 49.81 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Debt / Equity Ratio | 1.78 | 1.40 | 1.26 | 1.13 | 2.26 | 0.34 |
Debt / EBITDA Ratio | 2.67 | 2.54 | 2.67 | 2.50 | 2.40 | 0.39 |
Debt / FCF Ratio | 3.80 | 4.24 | 14.14 | 6.10 | 4.48 | 0.64 |
Net Debt / Equity Ratio | 1.72 | 1.35 | 1.22 | 1.08 | 2.18 | 0.26 |
Net Debt / EBITDA Ratio | 2.67 | 2.51 | 2.67 | 2.47 | 2.40 | 0.31 |
Net Debt / FCF Ratio | 3.67 | 4.06 | 13.65 | 5.82 | 4.33 | 0.48 |
Asset Turnover | 0.60 | 0.58 | 0.56 | 0.57 | 0.85 | 1.32 |
Inventory Turnover | 2.36 | 2.35 | 2.44 | 2.44 | 2.51 | 2.63 |
Quick Ratio | 0.88 | 0.94 | 0.62 | 0.37 | 0.72 | 0.70 |
Current Ratio | 1.56 | 1.61 | 1.02 | 0.61 | 1.20 | 1.11 |
Return on Equity (ROE) | 18.53% | 21.35% | 28.67% | 37.38% | 57.18% | 61.96% |
Return on Assets (ROA) | 10.12% | 10.01% | 9.49% | 10.00% | 16.23% | 27.08% |
Return on Invested Capital (ROIC) | 14.74% | 11.75% | 15.25% | 17.45% | 29.00% | 52.22% |
Return on Capital Employed (ROCE) | 19.10% | 18.40% | 19.30% | 21.50% | 23.00% | 66.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Earnings Yield | 2.82% | 2.97% | 2.57% | 2.85% | 2.86% | 2.25% |
FCF Yield | 6.39% | 4.37% | 0.81% | 1.91% | 2.53% | 2.04% |
Dividend Yield | 5.28% | 4.43% | 2.70% | 3.10% | 2.91% | 2.17% |
Payout Ratio | 187.59% | 136.36% | 93.43% | 88.79% | 85.87% | 79.38% |
Buyback Yield / Dilution | 0.08% | -0.22% | -4.36% | -1.27% | 0.19% | 0.05% |
Total Shareholder Return | 5.35% | 4.20% | -1.66% | 1.83% | 3.10% | 2.22% |